review Open AccessTop 1% cited
Class II histone deacetylases: versatile regulators
Trends in Genetics · 2003 · Vol. 19(5) · pp. 286–293
Eric Verdin✉(Gladstone Institutes)Samuel Dequiedt(University of California, San Francisco)Herbert G. Kasler(University of California, San Francisco)
Histone Deacetylase Inhibitors ResearchNuclear Receptors and SignalingProtein Degradation and InhibitorsBiologyAcetylationHistoneChromatinGeneticsHistone deacetylaseHistone codeHDAC4Histone methyltransferaseHistone H2A
MeSH terms
AnimalsHistone DeacetylasesHistonesHumansLysine
Funding
- Sandler Foundation
- Gladstone Institutes
- National Institutes of Health
Citations
655
FWCI
13.90
field-weighted impact
References
92
Percentile
99%
vs. same field & year
Citations per year
Cited by
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
Leukemia · 2008 · 439 citations
HDAC family: What are the cancer relevant targets?
Cancer Letters · 2008 · 1,047 citations
Prospects: Histone deacetylase inhibitors
Journal of Cellular Biochemistry · 2005 · 478 citations
Regulation of histone deacetylase activities
Journal of Cellular Biochemistry · 2004 · 345 citations
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Nature reviews. Cancer · 2006 · 2,190 citations
References
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
Molecular Cell · 2003 · 1,517 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.